Centene Corporation: shareholders and insiders

CNCNYSEHealthcare · Hospital & Medical Service Plans

Price

$72.55

November 17, 2026Market cap $35.7B

What Ploutos Investor adds for Centene

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 17 fiscal years, from 2009
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • Profit over the last twelve months is well above what the business itself earned, because it includes large gains outside the business, such as on investments or from selling a business. The P/E is lower than the business alone would give.

Insiders and their shares

Purchases and sales by officers and directors from Nov 18, 2025 to Oct 15, 2026, from their own Form 4 filings.

20 Form 4s

Bought on the market

–

nobody

Sold on the market

$15M

2 people

From Nov 18, 2025 to Nov 18, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

  • Under a set plan0%
  • The rest100%

By year

Insiders' open-market purchases (up) and sales (down), by value, since Nov 18, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.

2026·no buys·sold $12M by 2 people

  • 2025: no buys, sold $2.6M by 1 person
  • 2026: no buys, sold $12M by 2 people
  • Oct 15, 2026Michael A CarsonGroup President, Medicare&Spec
    Kind
  • Sep 30, 2026Lauren M TylerDirector
    Kind
  • Sep 30, 2026Kenneth TanjiDirector
    Kind
  • Sep 30, 2026Theodore R. Samuels IIDirector
    Kind
  • Sep 30, 2026Frederick H EppingerDirector
    Kind
  • Sep 30, 2026Christopher J CoughlinDirector
    Kind
  • Sep 15, 2026Theodore J PienkosCorporate Controller & CAO
    Kind
  • Aug 26, 2026Christopher KosterSecretary & General Counsel
    Kind
  • Aug 18, 2026Christopher KosterSecretary & General Counsel
    Kind
  • Jul 28, 2026Paul J DiazDirector
    Kind
  • Jul 17, 2026Lauren M TylerDirector
    Kind
  • Jun 30, 2026Lauren M TylerDirector
    Kind
  • Jun 30, 2026Kenneth TanjiDirector
    Kind
  • Jun 30, 2026Theodore R. Samuels IIDirector
    Kind
  • Jun 30, 2026Frederick H EppingerDirector
    Kind
  • Jun 30, 2026Christopher J CoughlinDirector
    Kind
  • Jun 15, 2026Susan Raye SmithChief Operating Officer
    Kind
  • Jun 10, 2026Kenneth A BurdickDirector
    Kind

From the Form 4s insiders file with the SEC within two business days of each trade. Before May 26, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.

Insiders and their shares

Every buy and sale by CNC's officers and directors from 2006 up to November 17, 2025, 20 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

3 Holders over 5%Apr 29, 2026 Latest filing
  • BlackRock, Inc.
    Share of class7.70%
  • Vanguard Capital Management
    Share of class7.30%
  • AQR Capital Management, LLCwith 1 more person
    Share of class6.47%
Fell to 5% or less (4)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • The Vanguard Group0.00%Mar 26, 202613G/A
  • FMR0.70%Nov 5, 202513G/A
  • Norges Bank1.40%Nov 4, 202513G/A
  • Harris Associates L P4.10%Aug 14, 202513G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Greenlight / DME (Einhorn)
    In the quarter
  • Glenview Capital
    In the quarter+25%
  • AQR Capital
    In the quarter+9.5%
  • Bridgewater (Dalio)
    In the quarter+236%
  • Renaissance Technologies
    In the quarter+79%
  • Point72 (Cohen)
    In the quarter+113%
  • D.E. Shaw
    In the quarter-45%
  • Millennium Mgmt (Englander)
    In the quarter-43%
  • Citadel Advisors (Griffin)
    In the quarter-53%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 2.22% of its shares outstanding were held short, +4.0% since the report before.

Shares held short
10.93M
2.22%
Since the report before10.51M on Sep 30, 2026
+4.0%
2.5
4.32M
More days to cover thanof 4,578 US-listed companies with enough volume
30%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 6.85M
  • Nov 15, 2023: Shares held short 7.21M
  • Nov 30, 2023: Shares held short 7.20M
  • Dec 15, 2023: Shares held short 7.38M
  • Dec 29, 2023: Shares held short 5.81M
  • Jan 12, 2024: Shares held short 6.93M
  • Jan 31, 2024: Shares held short 7.08M
  • Feb 15, 2024: Shares held short 8.25M
  • Feb 29, 2024: Shares held short 8.84M
  • Mar 15, 2024: Shares held short 9.60M
  • Mar 28, 2024: Shares held short 8.20M
  • Apr 15, 2024: Shares held short 7.59M
  • Apr 30, 2024: Shares held short 7.58M
  • May 15, 2024: Shares held short 9.49M
  • May 31, 2024: Shares held short 13.05M
  • Jun 14, 2024: Shares held short 12.65M
  • Jun 28, 2024: Shares held short 13.68M
  • Jul 15, 2024: Shares held short 13.54M
  • Jul 31, 2024: Shares held short 10.45M
  • Aug 15, 2024: Shares held short 9.77M
  • Aug 30, 2024: Shares held short 10.12M
  • Sep 13, 2024: Shares held short 9.62M
  • Sep 30, 2024: Shares held short 7.80M
  • Oct 15, 2024: Shares held short 8.09M
  • Oct 31, 2024: Shares held short 14.44M
  • Nov 15, 2024: Shares held short 15.16M
  • Nov 29, 2024: Shares held short 16.31M
  • Dec 13, 2024: Shares held short 19.25M
  • Dec 31, 2024: Shares held short 8.04M
  • Jan 15, 2025: Shares held short 5.62M
  • Jan 31, 2025: Shares held short 6.67M
  • Feb 14, 2025: Shares held short 9.78M
  • Feb 28, 2025: Shares held short 6.05M
  • Mar 14, 2025: Shares held short 9.91M
  • Mar 31, 2025: Shares held short 7.14M
  • Apr 15, 2025: Shares held short 10.56M
  • Apr 30, 2025: Shares held short 8.57M
  • May 15, 2025: Shares held short 10.93M
  • May 30, 2025: Shares held short 7.82M
  • Jun 13, 2025: Shares held short 9.31M
  • Jun 30, 2025: Shares held short 9.87M
  • Jul 15, 2025: Shares held short 13.44M
  • Jul 31, 2025: Shares held short 27.78M
  • Aug 15, 2025: Shares held short 23.68M
  • Aug 29, 2025: Shares held short 19.45M
  • Sep 15, 2025: Shares held short 19.58M
  • Sep 30, 2025: Shares held short 13.47M
  • Oct 15, 2025: Shares held short 13.68M
  • Oct 31, 2025: Shares held short 14.33M
  • Nov 14, 2025: Shares held short 15.24M
  • Nov 28, 2025: Shares held short 13.52M
  • Dec 15, 2025: Shares held short 12.59M
  • Dec 31, 2025: Shares held short 12.91M
  • Jan 15, 2026: Shares held short 12.23M
  • Jan 30, 2026: Shares held short 12.73M
  • Feb 13, 2026: Shares held short 14.38M
  • Feb 27, 2026: Shares held short 12.70M
  • Mar 13, 2026: Shares held short 11.70M
  • Mar 31, 2026: Shares held short 13.67M
  • Apr 15, 2026: Shares held short 13.76M
  • Apr 30, 2026: Shares held short 15.23M
  • May 15, 2026: Shares held short 15.14M
  • May 29, 2026: Shares held short 14.67M
  • Jun 15, 2026: Shares held short 14.80M
  • Jun 30, 2026: Shares held short 15.13M
  • Jul 15, 2026: Shares held short 13.44M
  • Jul 31, 2026: Shares held short 13.59M
  • Aug 14, 2026: Shares held short 13.27M
  • Aug 31, 2026: Shares held short 13.43M
  • Sep 15, 2026: Shares held short 14.13M
  • Sep 30, 2026: Shares held short 10.51M
  • Oct 15, 2026: Shares held short 10.93M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading46.6% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 46.6% of the shares in the reported trades were short sales, against 48.7% in the 14 before.

Last 14 sessionsOct 29, 2026 – Nov 17, 2026
46.6%
The 14 beforeOct 9, 2026 – Oct 28, 2026
48.7%
Change
-2.1 pts
Short sales a dayon average, of 2.19M shares
1.02M
More than atof 3,666 US-listed companies, same days
37%
Median of alleight in ten from 34.6% to 63.7%
50.3%
  • Oct 9, 2026: Short sales 51.5%
  • Oct 12, 2026: Short sales 45.2%
  • Oct 13, 2026: Short sales 49.9%
  • Oct 14, 2026: Short sales 45.5%
  • Oct 15, 2026: Short sales 51.8%
  • Oct 16, 2026: Short sales 38.4%
  • Oct 19, 2026: Short sales 43.5%
  • Oct 20, 2026: Short sales 40.8%
  • Oct 21, 2026: Short sales 43.6%
  • Oct 22, 2026: Short sales 46.3%
  • Oct 23, 2026: Short sales 39%
  • Oct 26, 2026: Short sales 36.2%
  • Oct 27, 2026: Short sales 64.6%
  • Oct 28, 2026: Short sales 56.2%
  • Oct 29, 2026: Short sales 39.5%
  • Oct 30, 2026: Short sales 41.9%
  • Nov 2, 2026: Short sales 49.9%
  • Nov 3, 2026: Short sales 37.4%
  • Nov 4, 2026: Short sales 51.4%
  • Nov 5, 2026: Short sales 49.5%
  • Nov 6, 2026: Short sales 48.9%
  • Nov 9, 2026: Short sales 39.2%
  • Nov 10, 2026: Short sales 44.9%
  • Nov 11, 2026: Short sales 51.6%
  • Nov 12, 2026: Short sales 38.6%
  • Nov 13, 2026: Short sales 51.8%
  • Nov 16, 2026: Short sales 40.4%
  • Nov 17, 2026: Short sales 54.8%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

2.97M Insiders' shares0.60% Of the company
  • Sarah LondonChief Executive Officer
    Directly845.3K
  • Andrew Lynn AsherChief Financial Officer
    Directly486.8K
  • Frederick H EppingerDirector
    Directly370.4K
  • Kenneth J FasolaPresident
    Directly300.4K
  • Christopher KosterSecretary & General Counsel
    Directly248.9K
  • Susan Raye SmithChief Operating Officer
    Directly212.2K
  • Kenneth A BurdickDirector
    Directly197.1K
  • Michael A CarsonGroup President, Medicare&Spec
    Directly116.6K
  • Theodore R. Samuels IIDirector
    Directly25.8K
  • Christopher J CoughlinDirector
    Directly49.3K
  • Theodore J PienkosCorporate Controller & CAO
    Directly28.8K
  • Thomas GrecoDirector
    Directly19.3K
  • Kenneth TanjiDirector
    Directly13.1K
  • Lori Jean RobinsonDirector
    Directly11.5K
  • Lauren M TylerDirector
    Directly3,698
  • Paul J DiazDirector
    Directly2,771
  • H James DallasDirector
    Directly–
  • Jessica L. BlumeDirector
    Directly–

A lower bound: it counts only the 18 officers and directors with a market trade since Nov 19, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

Executive pay

From the Pay versus Performance table every company puts in its proxy statement since 2023: what the chief executive was paid, what was actually paid once the shares vest at year-end values, and how the stock did against the peer group the company itself picked.

2025 Latest year6 Years on record

$20M

Actually paid: $4.6M

$0

Actually paid: $0

$7.7M

Actually paid: $3.2M

$69

Peers: $148

Adjusted Diluted EPS

From the proxy statement (DEF 14A) of Mar 26, 2026, as filed with the SEC with structured data. Pay in dollars. The company picks its own peer group and measure. DEF 14A

Share repurchases

How many of its own shares the company bought each quarter, at what average price, for how much, and what remains of the program its board authorized, from the table it puts in every 10-Q and 10-K.

$473M Repurchases over 4 quarters$1.8B Left in the program
  • Mar 31, 202610-Q
    Amount$30M
  • Dec 31, 202510-K
    Amount$2.1M
  • Jun 30, 202510-Q
    Amount$400M
  • Mar 31, 202510-Q
    Amount$41M
  • Dec 31, 202410-K
    Amount$934M
  • Sep 30, 202410-Q
    Amount$1.2B
  • Jun 30, 202410-Q
    Amount$803M
  • Mar 31, 202410-Q
    Amount$151M

From the "Issuer Purchases of Equity Securities" table of the 10-Qs and 10-Ks, read without a model. Only the quarters whose shares times average price agree with the cash the company says it paid for repurchases in its cash-flow statement are shown. The shares include those withheld for officers' taxes. A quarter with an accelerated repurchase shows the table's shares and the cash paid, without an average price. 3 filing(s) not shown, as the table was not read or did not agree with the cash.

The shareholders' vote on pay

The advisory say-on-pay vote at each annual meeting, as the company states it in the 8-K it files after the meeting: how many voted for and against the executives' pay. 90% is the norm. Under 70% proxy advisers expect the board to respond the next year.

91.6% For in 20266 Votes on record
  • 2026May 15, 2026
    For
    91.6%
  • 2025May 14, 2025
    For
    88.8%
  • 2024May 16, 2024
    For
    90.8%
  • 2023May 15, 2023
    For
    84.0%
  • 2022Apr 28, 2022
    For
    33.6%
  • 2021Apr 30, 2021
    For
    98.0%

From the 8-K (item 5.07) the company files after each annual meeting since 2021, read from the filing's text without a model. A company that votes every three years has empty years. The vote is advisory: the board is not bound by it.

The ETFs that hold it

Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

57 ETFs holding it4.22% The largest weight (IHF)
  • IHFiShares U.S. Healthcare Providers ETF
    Weight in the fund4.22%
  • RPVInvesco S&P 500 Pure Value ETF
    Weight in the fund2.53%
  • VFLOVictoryShares Free Cash Flow ETF
    Weight in the fund2.16%
  • RWLInvesco S&P 500 Revenue ETF
    Weight in the fund0.96%
  • AVLVAvantis U.S. Large Cap Value ETF
    Weight in the fund0.61%
  • FMDEFidelity Enhanced Mid Cap Core ETF
    Weight in the fund0.56%
  • SCHMSchwab U.S. Mid-Cap ETF
    Weight in the fund0.56%
  • XLVState Street(R) Health Care Select Sector SPDR(R) ETF
    Weight in the fund0.52%
  • IYHiShares U.S. Healthcare ETF
    Weight in the fund0.51%
  • VLUEiShares MSCI USA Value Factor ETF
    Weight in the fund0.50%

57 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

1,004 Managers, Q2 2026$31.3B Value of their positions
  • Q3 2025: Managers 851
  • Q4 2025: Managers 914
  • Q1 2026: Managers 871
  • Q2 2026: Managers 1,004

Institutional investors by quarter

The fund managers holding CNC, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 1,004 managers held 488M shares, worth $31.3B. During the quarter 222 opened a position, 89 closed one, 342 added and 337 trimmed.

The largest holders, Q2 2026

  • BlackRock
    In the quarter+4.1%
  • Vanguard Capital Management
    In the quarter+0.8%
  • AQR Capital
    In the quarter-15%
  • Vanguard Portfolio Management
    In the quarter+3.3%
  • State Street
    In the quarter+1.5%
  • Geode Capital Management
    In the quarter+2.5%
  • Wellington Management Group
    In the quarter+423%
  • Ameriprise Financial
    In the quarter+23%
  • Invesco
    In the quarter+5.3%
  • Harris Associates L P
    In the quarter-21%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

The full analysis

What do Centene's filings show?

Who buys and sells is one part of Centene's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about CNC's shareholders

Didn't find what you were looking for?

Ask us
Have CNC's insiders bought or sold?

From May 26, 2026 to Oct 15, 2026 Centene's insiders bought 0 and sold $12M of shares on the market. 0% of the sales were under set 10b5-1 plans.

Which well-known managers hold CNC?

9 of the managers we track held the shares on Sep 30, 2026. The largest position was AQR Capital's, worth $1.9B.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.